about
15-Lipoxygenase 1 interacts with phosphatidylethanolamine-binding protein to regulate MAPK signaling in human airway epithelial cellsIntracellular fibril formation, calcification, and enrichment of chaperones, cytoskeletal, and intermediate filament proteins in the adult hippocampus CA1 following neonatal exposure to the nonprotein amino acid BMAAMammalian E4 is required for cardiac development and maintenance of the nervous system.Cytoskeletal pathologies of Alzheimer diseaseMapping cofilin-actin rods in stressed hippocampal slices and the role of cdc42 in amyloid-beta-induced rods.Hirano bodies differentially modulate cell death induced by tau and the amyloid precursor protein intracellular domain.The presence of FAC1 protein in Hirano bodies.Neuropathology of Alzheimer's diseaseTransgenic Drosophila models of Alzheimer's disease and tauopathiesMicroRNA-related cofilin abnormality in Alzheimer's disease.ASIP Outstanding Investigator Award Lecture. New approaches to the pathology and genetics of neurodegenerationTransgenic mouse model for the formation of Hirano bodies.Visiting scientists to the USA from Japan and their representative works.Model Hirano bodies protect against tau-independent and tau-dependent cell death initiated by the amyloid precursor protein intracellular domain.Formation of Hirano bodies induced by expression of an actin cross-linking protein with a gain-of-function mutation.Cause or Effect: Misregulation of microRNA Pathways in Neurodegeneration.Study of arsenic accumulation in rice and evaluation of protective effects of Chorchorus olitorius leaves against arsenic contaminated rice induced toxicities in Wistar albino ratsPostsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Aβ and tau pathology in transgenic mouse models of Alzheimer's diseaseCorpora Amylacea in Neurodegenerative Diseases: Cause or Effect?Tau-based treatment strategies in neurodegenerative diseasesFormation of Hirano bodies after inducible expression of a modified form of an actin-cross-linking protein.Actin-ADF/cofilin rod formation in Caenorhabditis elegans muscle requires a putative F-actin binding site of ADF/cofilin at the C-terminus.Cytoplasmic inclusions of TDP-43 in neurodegenerative diseases: a potential role for caspases.miRNAs: Key Players in Neurodegenerative Disorders and EpilepsyClues to γ-secretase, huntingtin and Hirano body normal function using the model organism Dictyostelium discoideum.MicroRNAs -the next generation therapeutic targets in human diseases.MicroRNAs and Molecular Mechanisms of Neurodegeneration.A Simple Model to Study Tau Pathology.Impact of C24:0 on actin-microtubule interaction in human neuronal SK-N-BE cells: evaluation by FRET confocal spectral imaging microscopy after dual staining with rhodamine-phalloidin and tubulin tracker green.Understanding perspectives of signalling mechanisms regulating PEBP1 function.The Actin Cytoskeleton in SMA and ALS: How Does It Contribute to Motoneuron Degeneration?Association of AICD and Fe65 with Hirano bodies reduces transcriptional activation and initiation of apoptosis.Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's disease.Caspase-cleaved TAR DNA-binding protein-43 in Pick's disease.Requirements for Hirano body formationAre tau aggregates toxic or protective in tauopathies?Hirano body expression impairs spatial working memory in a novel mouse model.Neuronal expression of hippocampal cholinergic neurostimulating peptide (HCNP)-precursor mRNA in rat brain.Caspase-cleaved transactivation response DNA-binding protein 43 in Parkinson's disease and dementia with Lewy bodies.Autophagy contributes to degradation of Hirano bodies.
P2860
Q24321415-AD8815E9-596B-407E-AF3E-DAA360EF781DQ28239546-401F9987-1411-47A1-92F0-BA8DDBC03C08Q28588393-0D846F05-841F-43D4-A9AE-4AF56DCC1204Q30435267-E6BA013A-1542-474B-AB78-8A299F186BF7Q30655361-DD8F3E71-1715-46C3-9180-8A7B35265B43Q31165645-FF90C0D0-C15C-4E10-AF8B-ACFE0417C2EAQ31972969-6FD203AA-159D-47E4-835F-F394A27B8AC3Q33526568-1B1989A0-0E4B-4ACD-AB0E-D1C783BC8319Q33770749-F4788CE2-4A34-426E-B452-F2C3661C60D9Q33778743-2A239F3C-79E1-4305-8D20-2A5C664D13D4Q33816233-3EAD7CA5-4BF0-406D-A839-73CF72DB6F01Q34042057-1DC52795-99B2-4999-8483-9D69D88461EDQ34063910-5EA3DCDC-5EED-4FAA-B13D-889693AF5511Q34427848-C21B09B7-9BCF-436F-BB88-75C7321AECD3Q35613667-C0EEC62E-134E-4D84-9669-3CFF18F4E21CQ35875886-D4529450-DF5C-4DF8-9654-9A3A5E51D094Q36163209-B930CF58-DC57-450C-ADD3-F256759F57B1Q36221062-5DB25ED2-05FF-4F77-B824-6520EACC5E55Q36252820-4431D99F-E71F-40E3-97FE-EE91F1664F07Q37215861-1CA4C7A0-4E6C-471D-A048-6513FBB81B1AQ37232374-54A18CAD-AD44-47A6-AF11-6CC2DB7A0598Q37322303-95E9DB20-7F4A-4465-87E5-15688F4EFBE7Q37530731-D8324531-2C64-4A38-AFD5-DFB12187E5B9Q37535111-F24F03DE-360A-4A8D-89D7-DA65DDA27CD0Q38001474-FDDBEC3C-46BF-410E-99AA-D3E57AE708CAQ38176359-8C6EC370-0A79-4A6E-82FB-45020928EAB4Q38202497-A2DED4B3-285A-4D27-9DAC-770E7BA2F5D9Q38650776-D54FF2B4-98A4-4368-B78B-833326E31083Q38848988-C48F3888-47DE-425E-9E09-0106D731B995Q38888382-28DF11ED-0CCF-4CA6-BA06-0C2D1E1C94BCQ39274901-D942510E-CB53-4A92-8C27-E39F8334D80FQ39743557-731DF239-4E77-4B6C-A871-21D59CC1954AQ39960293-5D8889DA-13BF-47FF-8741-7B552A98B6D7Q40098657-AA9B7DF8-0F3A-4183-8881-0B0661960DEEQ40794548-7BABD4F0-D9F9-47F2-AA5C-1BF184B38EA4Q42024199-3DE467A0-314F-4342-ADF4-A4B536E743C4Q42128427-ACB9F450-9BAE-4982-AD7A-887F860DCA78Q42524455-7A6C4D59-88D0-40EB-9557-6AFC3E8649CDQ42739339-3EDC223B-F94B-4D84-BB20-697A736C6F6CQ43139492-B7FEBA00-09C7-4B62-99BD-C2867F84BBA5
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Hirano bodies and related neuronal inclusions.
@en
type
label
Hirano bodies and related neuronal inclusions.
@en
prefLabel
Hirano bodies and related neuronal inclusions.
@en
P2860
P1476
Hirano bodies and related neuronal inclusions.
@en
P2093
P2860
P356
10.1111/J.1365-2990.1994.TB00951.X
P577
1994-02-01T00:00:00Z